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Abstract
Background: Patients with chronic pain frequently display comorbid depression, but the impact of this
concurrence is often underestimated and mistreated. The aim of this study was to determine the prevalence of
unrecognized major depression and other mood disorders and comorbid unexplained chronic pain in primary care
settings and to explore the associated factors.
Also, to compare the use of health services by patients with unexplained chronic pain, both with and without
mood disorder comorbidity.
Methods: A cross-sectional study was carried out in a sample of primary care centers. 3189 patients consulting for
“unexplained chronic pain” were assessed by the Visual Analogue Scales (VAS) and the Primary Care Evaluation of
Mental Disorders (PRIME-MD) questionnaire.
Results: We report: a) a high prevalence of unrecognized mood disorders in patients suffering from unexplained
chronic pain complaints (80.4%: CI 95%: 79.0%; 81.8%); b) a greater susceptibility of women to mood disorders (OR
adjusted = 1.48; CI 95%:1.22; 1.81); c) a direct relationship between the prevalence of mood disorders and the
duration of pain (OR adjusted = 1.01; CI 95%: 1.01; 1.02) d) a higher comorbidity with depression if the pain
etiology was unknown (OR adjusted = 1.74; CI 95%: 1.45; 2.10) and, e) an increased use of health care services in
patients with such a comorbidity (p < 0.0001).
Conclusions: The prevalence of undiagnosed mood disorders in patients with unexplained chronic pain in primary
care is very high, leading to dissatisfaction with treatment processes and poorer outcomes. Consequently, it seems
necessary to explore this condition more regularly in general practice in order to reach accurate diagnoses and to
select the appropriate treatment.
Background
Chronic pain and depression are amongst the most
common health problems reported by patients attending
primary care [1]. Both conditions produce increased use
of health resources and impaired health-related quality
of life [2,3].
Chronic pain and depression are frequently comorbid
processes, with some studies showing a prevalence ran-
ging from 15% to 100% [4]. Likewise, the clinical pre-
sence and severity of chronic pain are recognized as
predictors of the degree of depression in these patients
[5,6] with the association of both processes producing a
greater impact on the patient than either disorder alone
[5,7].
Patients with comorbid chronic pain and depression
consult their doctor more often and become heavy con-
sumers of medical services [8,9]. Furthermore, some stu-
dies suggest that patients with depression and chronic
p a i na r em o r el i k e l yt ob ed i s s a t i s f i e dw i t ht h e i rh e a l t h -
care[10].
In primary care, depression is often undiagnosed, par-
ticularly in cases of patients suffering from chronic pain
[11]. The WHO study on psychological disorders in
general health care found that primary care physicians
detected only 39.1% of cases of current depression [12].
Bair et al [4] demonstrated that physicians in these
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patients with major depression and that the treatment
of somatic complaints often takes precedence over the
identification and treatment of depression [13].
From a neurobiological perspective, chronic pain and
depression share similar neurobiological mechanisms
and central nervous structures. For example, serotonin
and noradrenaline are implicated in both processes, and
it is well known that antidepressants that enhance sero-
tonin and noradrenaline are effective analgesics [14-16].
More recently, neuroimaging studies have supported
this relationship [17,18].
In spite of the overwhelming data demonstrating the
relationship between chronic pain and depression, stu-
dies concerning the comorbidity of chronic pain, espe-
cially unexplained chronic pain, with other mood
disorders are scarce. Most studies have focused on
pain’s relationship with Major Depressive Disorder
(MDD), with few addressing other mood conditions
such as minor depression, dysthymia or bipolar disorder
included in the Diagnostic and Statistical Manual of
Mental Disorders Fourth Edition (DSM-IV). Likewise,
studies using specific structured interviews to assess
these processes in primary care are not common.
By means of a structured interview, this study investi-
gated the prevalence of unrecognized mood disorders,
not only MDD, in patients with medically unexplained
chronic pain complaints in primary care settings, and
also studied possible factors associated with the comor-
bid mood disorder. As a secondary outcome we aimed
to compare the use of healthcare services in unexplained
chronic pain patients with and without comorbid mood
disorder.
Method
Study Design and Sampling Process
A cross-sectional study was carried out in a sample of
primary care centers in Spain between April 2006 and
December 2006. In order to obtain a representative
sample, the number of primary care centers chosen in
each Spanish region was proportionate to its number of
inhabitants. Likewise, the selection process observed
Spain’s rural/urban ratio with at least 20% of the sample
from primary care centers in cities of less than 50,000
inhabitants.
In each primary care center, one general practitioner
(GP) that voluntarily accepted to participate was
selected, constituting a final sample of 600 GPs.
The study was conducted in agreement with the Hel-
sinki Declaration and with standard working procedures
and protocols, and approved by the Clinical Research
Ethics Committee at the Clinical and Provincial Hospital
in Barcelona, ensuring adherence to the norms of good
clinical practice.
Patient Population
The study included men and women over 18 years of
age who consulted their Primary Care Center for unex-
plained pain (head, neck, back, limbs or joints) lasting
for at least 6 weeks. Thus, patients were considered with
“unexplained chronic pain” and eligible for the study if
the cause of their pain was either unknown or, in
known, the cause was not fully explained by another
medical or psychiatric disorder [19]. The presence of
pain for 6 weeks or more was considered to be the cri-
terium for chronic pain for the purpose of this study.
Likewise, patients did not have a current diagnosis of
any mood disorder in their medical record; they had to
be mentally and physically able to participate in the
study and had to give their written, informed consent.
Sample Size
To obtain a prevalence of unexplained chronic pain and
concomitant mood disorders of 20% with an accuracy of
3% and a confidence interval of 95%, based on the lit-
erature [20], the minimum number of patients was 683.
A sample size of 3285 patients was calculated to be able
to detect differences between sub-groups defined by age,
sex and treatment type considering an OR = 1.5 with a
confidence level of 95%, a power of 80%. This number
assumed a probability of exposure to the factor under
study of 15% in the group with concomitant mood dis-
order and also a ratio of 4 patients with mood disorders
versus 1 without. Assuming a possible 10% drop-out
rate due to incomplete data and absentees the final size
necessary for the study was established at 3641 patients.
Recruitment
To obtain the calculated number of patients each of the
600 selected GPs had to interview about 7 patients who
consulted them and who fulfilled the inclusion criteria
for the study. The patients were selected consecutively
based on arrival at the primary care center, and patients
who refused to participate were substituted for the next
one who fulfilled the criteria.
Measurements
The interviews were performed at local primary care facil-
ities by GPs who received a written guideline with instruc-
tions on the procedure to be used to collect that data.
Information related to socio-demographic variables (age,
sex, and educational level), clinical variables (duration of
pain, location of pain, pain treatment i.e. analgesics and/or
psychotropics, and quality and duration of sleep) and use
of healthcare resources (number of visits to doctors and
hospital as a consequence of the pain in the previous 6
weeks/diagnostic tests related to the pain in the previous 6
weeks) was collected from a structured questionnaire and
from the medical records of the patients.
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Analogical Scale (VAS) with a range of 0-100, where 0
was no pain and 100 was the worst pain possible [21].
For the detection and assessment of mood disorders the
module of mood state from the Primary Care Evaluation
of Mental Disorders (PRIME-MD) questionnaire was
used. This questionnaire, designed by Spitzer et al [22]
to help in the diagnosis of the most commonly observed
mood disorders observed specifically in primary care, is
based on the diagnostic criteria of the Diagnostic and
Statistical Manual of Mental Disorders Fourth Edition
(DSM-IV) and their sensibility and specificity are 83%
and 88% respectively. A Spanish validated version of the
PRIME-MD was used [23].
All possible PRIME-MD diagnoses according DSM-IV
criteria were considered in our study: major depressive
disorder, minor depressive disorder, partial remission
from a major depressive disorder, dysthymic disorder,
bipolar disorder or depression caused by a general medi-
cal condition, medication or drugs.
Data collection forms were further monitored centrally
to check and correct missing data or inconsistencies.
Statistical Analysis
In the descriptive analysis, absolute frequency and 95% CIs
were calculated for categorical variables, and central trend
and dispersion measurements were used for quantitative
variables. The T- test, Wilcoxon test or chi-squared test
(Student or Fisher) were used to study associations.
The prevalence (CI 95%) of undiagnosed mood disor-
der was calculated as the number of patients with an
undiagnosed illness detected with the PRIME-MD ques-
tionnaire divided by the total number of patients
screened with the PRIME-MD questionnaire.
To study the factors associated with mood disorders, a
backward logistic regression model was used in which
the outcome variable was the presence or absence of
mood disorders, and the variables included in the model
were: sex, age, location of pain (head, neck, back, joints),
intensity of pain, duration of pain expressed as the per-
centage of the day in pain, number of pain locations,
known cause of the pain (yes/no) and current treatment
(non-steroidal anti-inflammatory drugs (NSAIDs),
analgesic opioids, anticonvulsants, anxiolitics). The vari-
ables were selected according to the statistical signifi-
cance observed in the univariate analysis (p < 0.05) or
according to the association with the dependent vari-
ables observed in the literature. The Hosmer-Lemeshow
test was used to assess the goodness of fit of the model.
Results
Population Characteristics
3588 patients were initially included in the study, of
whom 399 were excluded (75 had a current diagnosis of
depression, 41 had suffered pain for less than 6 weeks,
50 had a limitation when responding to the PRIME-MD
questionnaire, 171 refused to participate and 199 had
correctly filled in less than 80% of the information).
Thus, the final number of patients studied was 3189
(response rate 88.9%) all of whom gave their written
informed consent to participate in the study.
The average age of the population was 53.9 (SD: 13.3),
72.8% were female, 78.9% had completed primary or
secondary education and 64% lived with a partner.
The average duration of pain was 30.8 months (med-
ian 13.9), the average intensity on the VAS was 55.9
(SD: 19.8), the most common locations of pain were the
neck and back (Table 1) and the average number of
pain locations was 3.5 (SD: 1.4). Also, in the 1154
patients (38.3%) where the etiology of the pain was
known but the intensity was not fully explained by this
Table 1 Characteristics of pain and its treatment in the
patients studied
Duration of pain (months) N 1393
Mean (SD) 30.8 (43.5)
Median (P25; P75) 13 (6.0; 37.0)
Intensity of pain (VAS) N 3189
Mean (SD) 55.9 (19.8)
Median (P25; P75) 56 (42.5; 70.0)
Pain location
a N = 3189 %
- Head 2063 64.7
- neck 2282 71.6
- back 2283 71.6
- limbs 1865 58.5
- joints 1954 61.3
Specific known etiology (yes
)b N = 1154 38.3%
- Musculoskeletal and
connective tissue disorder
898 77.8
- Nervous system disorder 155 13.4
- Anxiety/Somatic disorder 117 10.1
- Metabolism disorder 70 6.1
- Vascular disorder 49 4.2
- Other disorders (neoplasias,
digestive inmune, etc)
151 13.1
Current treatment
c N = 3004 94.2%
- Analgesics* 2729
◦ NSAIDs 2623 96.1
◦ Opioids 290 10.6
- Psychotropics* 1262
◦ Anxiolitics/Hypnotics 971 76.9
◦ Anticonvulsivants 99 7.8
a More than 1 site was possible
b More than 1 etiology was possible
c More than 1 treatment was possible
SD: Standard Deviation; P25: Percentile 25; P75: Percentile 75.
* alone or in combination
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keletal or connective tissue pathologies (77.8%).
Of all the patients studied, 94.2% (n = 3005) were
undergoing some type of treatment for pain at the time
of inclusion in the study. Of the 2729 patients under
treatment with analgesics (alone or in combination with
psychotropic drugs), 96.1% were taking a simple analge-
sic or NSAIDs, especially acetaminophen (54%) or ibu-
profen (26%), and 10.6% were taking opioid analgesics
(in particular tramadol, 60%) (Table 1). Of the 1262
patients taking psychotropic drugs (alone or in combina-
tion with analgesics), 76.9% were taking benzodiazepines
(anxiolitics/hypnotics) (Table 1).
Out of the 3156 patients answering the first question
concerning sleep, 70.3% said they slept fewer hours due
to the presence of pain, and of 3141 patients answering
the second question related to sleep 46.7% said that the
pain symptoms were the cause of interrupted sleep.
As for the use of healthcare resources (Table 2), it
should be pointed out that, due to the pain, patients
had consulted a doctor at their primary care centre in
the previous six weeks an average of 3.2 times; and 1546
patients (48.9% of the sample) had undergone at least 1
test to diagnose the symptoms.
Prevalence of undiagnosed mood disorder and
associated factors
The prevalence of comorbid mood disorders detected by
PRIME-MD was 80.4% (CI 95%: 79.0%; 81.8%). Comor-
bidity was higher in the female population (82.8% vs
75.4% in males; p < 0.0001) but there were no differ-
ences related to patients’ age (p = 0.42).
The type of mood disorder most frequently diagnosed
was major depression (56.2%), followed by minor
depression (17.8%) and dysthymia (16.9%) (Table 3).
The analysis of the factors associated with the presence
of mood disorders in patients suffering from unexplained
chronic pain can be seen in Table 4, which highlights the
following factors as most strongly associated with mood
disorders: being female, severe intensity of pain, longer
duration of pain, pain located in the head, neck, joints or
back, number of pain locations, the lack of knowledge
regarding the cause of the pain, and taking anxiolytics or
NSAIDs (Table 4). Being female, the presence of head-
aches, the cause of the pain being unknown and taking
anxiolytics were risk factors associated independently
with the presence of comorbid mood disorders in these
patients. Similarly, the duration of pain in the previous
week was a risk factor for mood disorders and taking
NSAIDs was a protective factor. (Table 5).
Use of healthcare resources in patients with chronic pain
and mood disorders
As displayed in Table 2, the use of healthcare resources
was significantly higher in patients with comorbid unex-
plained pain and any mood disorder compared to those
only suffering from unexplained pain. Comorbid patients
Table 2 Use of healthcare resources in patients with unexplained pain with or without mood disorders
Variable Total Without Mood Disorder With Mood Disorder p-value
a
Number of visits to primary N 2818 549 2269
healthcare doctor due to pain Mean (SD) 3.20 (2.16) 2.81 (2.10) 3.29 (2.17) <0.0001
in the previous 6 weeks Median(P25; P75) 3.0 (2.0; 4.0) 2.0(2.0; 3.0) 3.0(2.0; 4.0)
Number of visits to a N 1261 214 1047
specialist due to pain in the Mean (SD) 1.14 (1.27) 0.97 (1.23) 1.18 (1.27) 0.0080
previous 6 weeks. Median(P25; P75) 1.0 (0.0; 1.0) 1.0 (0.0; 1.0) 1.0 (1.0; 1.0)
Number of tests undergone N 1541 292 1249
for the diagnosis of pain in Mean (SD) 1.47 (1.04) 1.50 (1.14) 1.46 (1.02) 0.6441
the previous 6 weeks. Median(P25; P75) 1.0 (1.0; 2.0) 1.0 (1.0; 2.0) 1.0 (1.0; 2.0)
Number of hospitalizations due N 627 114 513
to pain in the previous year Mean (SD) 0.36 (1.05) 0.38 (1.42) 0.36 (0.95) 0.3749
Median(P25; P75) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0)
a Wilcoxon Test
SD: Standard Deviation; P25: Percentile 25; P75: Percentile 75.
Table 3 Prevalence (CI 95%) of mood disorders in the
population studied detected by PRIME-MD
Mood Disorder N Prevalence
(CI 95%)
Major Depressive Disorder 1792 56.2 (54.5; 57.9)
Minor Depressive Disorder 567 17.8 (16.5; 19.1)
Dysthymia 539 16.9 (15.6; 18.2)
Bipolar Disorder 46 1.4 (1.1; 1.9)
Depression caused by medical condition,
medication or drugs
80 2.5 (2.0; 3.1)
Partial remission from major depressive disorder 207 6.5 (5.7; 7.4)
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quency. However, no differences were observed between
the groups regarding the number of diagnostic tests car-
ried out or hospitalization rates (Table 2)
Discussion
This study was undertaken to investigate the comorbid-
ity of unrecognized mood disorders and unexplained
chronic pain in primary care patients, as well as to
determine the possible factors influencing such a rela-
tionship. In addition, the study also investigated the use
of healthcare resources as a consequence of this
comorbidity.
The most important findings related to the aim of our
study were: a) the existence of a high prevalence of
undiagnosed mood disorders in patients suffering from
unexplained chronic pain complaints evaluated in a pri-
mary care setting; b) the frequent presence in these
patients of other mood disorders, different to MDD c) a
greater susceptibility of women to mood disorders; d) a
direct relationship between the prevalence of mood dis-
orders and the duration of pain in the previous week; e)
an absence of association between the intensity and
number of pain-sites; f) a higher comorbidity if the rea-
sons for suffering pain are unknown and, g) the observa-
tion of an increased use of healthcare services in
patients with such comorbidity.
Our results confirm previous studies reporting that
the presence of painful physical symptoms increases the
likelihood of a diagnosis of a mood or anxiety disorder
by as much as 3-fold [24]. Also, they are in agreement
with data reported by Tang et al [25] who concluded
that in chronic back pain patients, experimentally
induced negative mood increased self-reported pain and
decreased tolerance, with positive mood having the
opposite affect.
Table 4 Factors associated with the presence of mood disorder (univariate analysis)
Variable Level N OR CI (95%) p-value
Sex Female vs Male 3076 1.51 (1.5; 1.83) <0.0001
Age (years) < 30 2720 1
a 0.0920
30-39 1.29 (0.84; 4.12)
40-49 1.48 (0.56; 1.93)
50-59 1.04 (0.73; 2.35)
60-69 1.31 (0.59; 1.84)
70-79 1.04 (0.83; 2.63)
≥ 80 1.86 (0.70; 2.38)
Pain intensity No pain (VAS ≤ 40) 3189 1
a <0.0001
Moderate pain (VAS 41-70) 1.37 (1.11; 1.68)
Severe pain (VAS >70) 1.95 (1.51; 2.53)
Duration of pain (months) > 2 years 1393 1
a 0.2824
< 6 months vs >2 years 1.21 (0.85; 1.73)
Between 6-12 months vs > 2 years 1.28 (0.88; 1.87)
Between 1-2 years vs > 2 years 0.91 (0.63; 1.31)
NSAIDs Yes vs No 3189 0.67 (0.52; 0.86) 0.0018
Analgesic opioids Yes vs No 3189 1.07 (0.79; 1.46) 0.6600
Anticonvulsionants Yes vs No 3189 1.03 (0.62; 1.71) 0.9181
Anxiolitics Yes vs No 3189 1.56 (1.27; 1.91) <0.0001
Headache Yes vs No 3189 1.66 (1.39; 1.99) <0.0001
Neck pain Yes vs No 3189 1.70 (1.41; 2.04) <0.0001
Back pain Yes vs No 3189 1.66 (1.38; 1.99) <0.0001
Limb pain Yes vs No 3189 1.24 (1.04; 1.48) 0.0165
Joint pain Yes vs No 3189 1.52 (1.27; 1.81) <0.0001
Identification of the cause of pain No vs Yes 3011 1.72 (1.44; 2.06) <0.0001
Pain duration in the last week (percentage of the day in pain) 3189 1.02 (1.01; 1.02) <0.0001
Number of pain sites 1 2959 1
a <0.0001
2 1.21 (0.87;1.67)
3 1.71 (1.23; 2.36)
4 1.91 (1.36;2.68)
5 2.54 (1.86;3.47)
a reference category
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mood disorders are frequently undetected. A number
of studies have found that about half of the patients
who experience major depression are not diagnosed by
their primary care physicians [26]. In addition, 50% to
80% of patients with depression initially have a painful
physical symptom [11]. These data would suggest that
these individuals are considerably less likely to receive
an accurate psychiatric diagnosis, will have a limited
access to specific treatments and a poor outcome. Rijs-
wijk and colleges [27] report some factors which serve
as barriers for suitable mental health care for GPs, and
they mention the difficulties in distinguishing between
psychological problems and a complete psychiatric dis-
order, or the difficulties in assessing severity of the dis-
order, as the most important. In this regard, it is worth
highlighting the high percentage of patients in this
study who had not received a diagnosis of mood
disorder.
One result found in this study, and which, to our
knowledge has not been reported by other authors is
the high frequency of minor depression or dysthymia
observed in the patients. The presence of these mood
disorders in almost 35% of the patients could be
explained by the use of the PRIME-MD, which is better
able to detect these processes in primary healthcare
than instruments used in other studies.
Our study also found that women suffer a greater risk
of experiencing a comorbid pain-mood disorder. This
result is congruent with findings by Ohayon and Schatz-
berg [6]. Campbell et al [3] and Keogh et al [28] also
suggested that there is evidence that comorbid chronic
pain and depression is more likely to occur in women
than in men. However, Arnow et al [29] found that the
degree of the comorbidity between chronic pain and
depression does not differ according to age or gender.
Although differences in pain reporting between women
and men are partly attributable to social conditioning
and to psychosocial factors, some experimental studies
have described sex differences in sensitivity to noxious
stimuli, suggesting that biological mechanisms underlie
such differences [30].
In this study, a direct association was found between the
number of pain sites and the presence of mood disorder,
as measured by the crude OR, but this relationship disap-
peared after adjustment by other variables. These data are
contradictory when we refer to previous studies [2]. Gureje
e ta l .[ 3 1 ] ,w h oa n a l y z e dd a t af r o mt h eW o r l dH e a l t h
Organization to examine persistent pain in primary care
patients around the world, found that half of patients who
experienced persistent pain at onset continued to have
persistent pain 12 months later. In this study, the best
independent predictor of persistent pain was the number
of pain sites. Moreover, in a more recent study, Gureje et
al. [32] found increased rates of depression and anxiety in
patients complaining of multi-site pain. The cause of such
contradictions may result from methodological differences,
related to differences in design, populations studied and
also probably due to the fact that we have adjusted for
intensity and duration of pain.
We found a higher rate of comorbid pain-mood disor-
der if the reasons for suffering pain are unknown, and
also when a precise diagnosis of the cause of pain is
lacking. In some studies, a higher occurrence of depres-
sion is reported if the etiology of the pain condition is
medically unexplained when compared to patients with
a more defined pain disorder, such as neuropathy [33].
Marazziti et al [33] explain that patients with unex-
plained pain have a higher likelihood of reporting cata-
strophic thoughts and they tend to think that the origin
of their pain is a mystery; they feel that they have lost
control and that their physician does not believe their
pain to be real.
Finally, we found an increased use of health care ser-
vices when pain is comorbid with mood disorder. This
result is replicated very often in other studies [34]. The
possible explanation of this coincidence is that the pre-
sence of mood disorder complicates the management of
patients with pain, resulting in a poor outcome, i.e.
longer duration of pain and a greater likelihood of non
recovery [4]. In this regard, some GPs declare factors
such as depression or anxiety to be among the most sig-
nificant and problematic complications in treating
patients with chronic pain [35].
It is necessary to know the complex biological rela-
tionships between chronic pain and depression to better
understand the frequency of this comorbidity. The con-
vergence of depression and pain is reflected in the cir-
cuitry of the nervous system. Brain pathways that
handle the reception of pain signals, including the lim-
bic system, use some of the same neurotransmitters
involved in the regulation of mood, especially serotonin
and norepinephrine. When an alteration occurs in these
pathways pain is intensified, along with depression and
Table 5 Logistic regression model of the variables
associated with the presence of mood disorder in
patients with pain (OR adjusted ± CI 95%) N = 2907
Variable Level OR CI (95%) p-value
Sex Male vs Female 1.48 (1.22; 1.81) 0.0001
NSAIDs Yes vs No 0.67 (0.51; 0.88) 0.0051
Anxiolitics Yes vs No 1.07 (1.11; 1.66) 0.0086
Headache Yes vs No 1.39 (1.15; 1.70) 0.0008
Duration of pain
in the last week
1.01 (1.01;1.02) 0.0001
Identification of
the cause of pain
No vs Yes 1.74 (1.45; 2.10) <0.0001
Hosmer-Lemeshow = 11.21 p = 0.189 c
2 = 160.46; p < 0.0001
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antidepressants - mainly those that inhibit the reuptake
of norepinephrine or serotonin - are used, either alone
or in combination with analgesics, to treat chronic pain
[15].
A limitation of our study is that the occurrence of
other chronic medical or psychiatric conditions, has not
been assessed and they are sometimes related to depres-
sion and often prevalent among people with chronic
pain [36,37]. Furthermore, the survey conducted was a
cross-sectional study and consequently does not provide
information about the direction of causality between
unexplained chronic pain and mood disorders. We can
therefore only postulate on the possible way in which
the association between pain and mood disorder is
established. Some explanations have been offered; it has
even been suggested, that certain pain conditions, such
as migraine [38], share a common predisposition with
some psychiatric disorders [32]. However, more follow-
up studies are necessary to improve our understanding
of chronic pain-mood disorder relationships in primary
care.
We have to point out the possible bias related to the
subjective assessment of pain by the GP in order to con-
sider the patients as being affected by unexplained
chronic pain and thus to select the patients to be
included in the study. However, this bias should be
small because of the training given to the GP, and
because of the use of objective assessment of pain by
a VAS.
Another limitation could be the lack of a confirmation
of the diagnosis by means of a structured psychiatric
interview. However the PRIME-MD is an instrument
with tried and tested psychometric properties.
A strength of this study is that our results are based
on large datasets collected from a broad range of pri-
mary care centres by means of objective assessment of
pain and using international criteria for mood disorder
diagnosis from a validated tool.
Conclusion
There is a very high under diagnosed prevalence of dif-
ferent mood disorders in patients with unexplained
chronic pain visiting a primary care physician, leading to
dissatisfaction with treatment processes and outcomes.
Consequently, it seems necessary to explore this condi-
tion more regularly in general practice in order to
achieve accurate diagnoses and to select the appropriate
treatment.
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